Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Letsch

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104)Anne Marie Asemissen, Carmen Scheibenbogen, Anne Letsch, et al.
Gynecologic Oncology|January 2, 2016
Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinomaEliane Tabea Taube, Carsten Denkert, Jalid Sehouli, et al.
Journal of Psychosomatic Research|January 6, 2023
The German version of the body image scale: Validation and item response analysis in cancer patientsTim J Hartung, Michael Friedrich, Peter Esser, et al.
European Journal of Dermatology : EJD|April 15, 2011
Clinically misinterpreted melanoma metastases can correctly be diagnosed by ultrasound-guided fine needle aspiration cytologyGregor Schaefer-Hesterberg, Alexander J C Van Akkooi, Anne Letsch, et al.
Blood|December 24, 2005
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2Robert Godal, Ulrich Keilholz, Lutz Uharek, et al.
BMC Palliative Care|May 14, 2020
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM)Nele Harnischfeger, Hilke M Rath, Anneke Ullrich, et al.
Journal of Translational Medicine|January 22, 2005
T cell responses against tumor associated antigens and prognosis in colorectal cancer patientsDirk Nagorsen, Carmen Scheibenbogen, Anne Letsch, et al.
International Journal of Cancer|May 7, 2002
Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptidesCarmen Scheibenbogen, Dirk Nagorsen, Barbara Seliger, et al.
Cancer Immunology, Immunotherapy : CII|March 12, 2020
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivoAnja Tatjana Teck, Sabrina Urban, Petra Quass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reactionUlrich Keilholz, Petra Goldin-Lang, Nikolaos E Bechrakis, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104)Anne Marie Asemissen, Carmen Scheibenbogen, Anne Letsch, et al.
Gynecologic Oncology|January 2, 2016
Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinomaEliane Tabea Taube, Carsten Denkert, Jalid Sehouli, et al.
Journal of Psychosomatic Research|January 6, 2023
The German version of the body image scale: Validation and item response analysis in cancer patientsTim J Hartung, Michael Friedrich, Peter Esser, et al.
European Journal of Dermatology : EJD|April 15, 2011
Clinically misinterpreted melanoma metastases can correctly be diagnosed by ultrasound-guided fine needle aspiration cytologyGregor Schaefer-Hesterberg, Alexander J C Van Akkooi, Anne Letsch, et al.
Blood|December 24, 2005
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2Robert Godal, Ulrich Keilholz, Lutz Uharek, et al.
BMC Palliative Care|May 14, 2020
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM)Nele Harnischfeger, Hilke M Rath, Anneke Ullrich, et al.
Journal of Translational Medicine|January 22, 2005
T cell responses against tumor associated antigens and prognosis in colorectal cancer patientsDirk Nagorsen, Carmen Scheibenbogen, Anne Letsch, et al.
International Journal of Cancer|May 7, 2002
Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptidesCarmen Scheibenbogen, Dirk Nagorsen, Barbara Seliger, et al.
Cancer Immunology, Immunotherapy : CII|March 12, 2020
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivoAnja Tatjana Teck, Sabrina Urban, Petra Quass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reactionUlrich Keilholz, Petra Goldin-Lang, Nikolaos E Bechrakis, et al.
Pageof 9